ATAP thanks Florida Governor Rick Scott for signing the Prescription Drug Pricing Transparency legislation into law on Friday. The law will allow pharmacists to share whether the retail price of a drug is less than the amount a consumer would pay under their insurance, preventing Florida consumers from being overcharged when they purchase many prescription medicines.
Read MoreOn behalf of the Alliance for Transparent and Affordable Prescriptions (ATAP), I am writing to express our support for HB 351, a bill that seeks to increase transparency and regulation of pharmacy benefit managers (PBMs), and urge you to sign it into law.
Read MoreA House committee opened hearings Tuesday on a bipartisan bill designed to lower the cost of prescription drugs.House Bill 479 — sponsored by Reps. Scott Lipps, R-Franklin, and Thomas E. West, D-Canton — takes aim at pharmacy benefit managers, known as PBMs, and other third-party administrators that operate as a middleman between insurance and drug companies.
Read MoreATAP is pleased to report that a Florida bill aimed at regulating PBMs has passed unanimously through the House and Senate and now heads to Governor Rick Scott.
Read MoreATAP is pleased to announce that New York has become the newest state to pass PBM reform legislation. Sponsored by Assemblymember Linda Rosenthal, A8781 was passed unanimously by both the Florida House and Assembly and is waiting to be signed into law by Governor Andrew Cuomo.
Read MoreThe Alliance for Transparent & Affordable Prescriptions (ATAP) is encouraged by UnitedHealthcare’s announcement that it will start passing on savings from drug manufacturers directly to patients by applying manufacturer rebates and discounts to their medication costs at the point of sale.
Read MoreATAP is pleased to report that a Virginia bill aimed at regulating PBMs (HB 1177), championed by Delegate Todd Pillion (R, 4th), has passed both the House and the Senate and is now headed to Governor Ralph Northam’s desk. Should the Governor sign HB 1177 into law, Virginia will become the first state to enact PBM legislation during the 2018 session.
Read MoreATAP is pleased to report that a Florida bill aimed at regulating PBMs (HB 351) has cleared another important hurdle: the Health and Human Services Committee yesterday voted unanimously in favor of passing the bill out of committee. ATAP sent a letter to Committee Members earlier this week expressing our support for HB 351 and urging them to support this legislation and vote in favor of the bill.
Read MoreThe Alliance for Transparent & Affordable Prescriptions (ATAP) applauds the White House for recognizing the increasingly harmful role of pharmacy benefit managers (PBMs) in the prescription drug market in a report released Friday outlining policy options to reduce drug prices and encourage medical innovation.
Read MoreOn February 7, ATAP sent a letter to New Hampshire legislators expressing its support for HB 1529, which seeks to increase transparency for pharmacy benefit managers (PBMs) by requiring them to annually disclose the amount of rebates and discounts received from drug manufacturers. The bill is currently being considered by the House Commerce and Consumer Affairs Committee, following a public hearing on its provisions.
Read More